728 patents currently held
28 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Mar 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
83
Ending by 2030
Mar 2027
Next term end
440
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2027 · High confidence
Also notable
Ends Jul 2031 · High confidence
Also notable
Ends Feb 2032 · High confidence
Also notable
Ends Oct 2036 · High confidence
Also notable
Ends May 2031 · High confidence
Also notable
Ends Dec 2036 · High confidence
Also notable
Ends Dec 2035 · High confidence
Also notable
Ends Apr 2037 · High confidence
Albumin Fusion Proteins Comprising GLP-1 Polypeptides
US 7,141,547
The most cited patent in this portfolio, cited by 241 later US patents, top 5% of utility patents granted in 2006 in our data. Protection runs to 2027.
Compositions for saccharification of cellulosic material
US 8,580,536
Cited by 67 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
Processes for Producing Fermentation Products
US 9,816,112
Cited by 28 later US patents, top 25% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Polypeptides
US 10,954,497
Cited by 13 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2036.
Methods for Producing Polypeptidies in Protease-Deficient Mutants of Trichoderma
US 8,986,974
Cited by 25 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
Process of Extracting Oil from Thin Stillage
US 11,028,378
Cited by 9 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2036. A terminal disclaimer caps this term to an earlier patent's.
Compositions Comprising Polypeptides Having Xylanase Activity and Polypeptides Having Arabinofuranosidase Activity
US 10,711,259
Cited by 15 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2035.
Cleaning Compositions Comprising Enzymes
US 11,414,652
Cited by 10 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2037. A terminal disclaimer caps this term to an earlier patent's.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 23, 2026The maintenance fee for Improving The Rollability of Flat Breads (US 11,653,655) comes due Nov 23, 2026. Unpaid by May 24, 2027, it lapses early.
- 11 fees due Dec 4 to 30, 2026 · next Dec 4
- 14 fees due Jan 2 to 30, 2027 · next Jan 2
- 15 fees due Feb 1 to 28, 2027 · next Feb 1
- 12 fees due Mar 3 to 29, 2027 · next Mar 3
- 18 fees due Apr 1 to 30, 2027 · next Apr 1
- 10 fees due May 3 to 28, 2027 · next May 3
- 12 fees due Jun 3 to 30, 2027 · next Jun 3
- 11 fees due Jul 2 to 30, 2027 · next Jul 2
- 20 fees due Aug 4 to 25, 2027 · next Aug 4
- 15 fees due Sep 1 to 26, 2027 · next Sep 1
- 20 fees due Oct 2 to 23, 2027 · next Oct 2
- 10 fees due Nov 3 to 19, 2027 · next Nov 3
Recent changes
- 16 of the patents on this record were granted since Aug 23, 2026
- 5 terms have ended since Aug 23, 2026
- Oct 9 US 10,093,911 Subtilisin Variants and Polynucleotides Encoding Same · lapsed on the fee record
- Sep 29 US 11,447,723 Polypeptide Variants · surrendered on reissue
- Sep 18 US 10,077,531 Improving Drainage of Paper Pulp · lapsed on the fee record
- Sep 4 US 7,867,743 Polypeptides Having Phytase Activity and Polynucleotides Encoding Same · term ended
- Aug 23 US 11,421,379 Enzymatic Treatment of Cellulosic Textile · lapsed on the fee record
What they patent
The largest of its 440 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Processes of Producing Fermentation Products | 8 in force | to Mar 2033 |
| Compositions for saccharification of cellulosic material | 8 in force | to Jul 2031 |
| Processes for Producing Fermentation Products | 7 in force | to Feb 2032 |
| Methods for Producing Polypeptidies in Protease-Deficient Mutants of Trichoderma | 7 in force | to May 2031 |
| Process of Recovering Oil | 6 in force | to Jun 2034 |
| Glucoamylase Variants and Polynucleotides Encoding Same | 6 in force | to Feb 2033 |
| Compositions of High Stability Alpha Amylase Variants | 6 in force | to Sep 2032 |
| Subtilase Variants and Polynucloetides Encoding Same | 5 in force | to Feb 2036 |
| Liquid Cleaning Compositions Comprising Protease Variants | 5 in force | to Jul 2035 |
| Chitooligosaccharides and Methods for use in Enhancing Plant Growth | 5 in force | to Apr 2033 |
| Cellulolytic Enzyme Compositions and Uses Thereof | 5 in force | to Aug 2032 |
| Alpha-Amylase Variants | 5 in force | to Jun 2032 |
| Management of Pathogenic Lawsonia | 4 in force | to Feb 2039 |
| Process of Extracting Oil from Thin Stillage | 4 in force | to Dec 2036 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,877,471 | Phytase Variants held by Novozymes A/S In force · Medium confidence | In force | Medium confidence | |
| US 10,041,052 | Phytase Variants held by Novozymes A/S In force · Medium confidence | In force | Medium confidence | |
| US 9,550,961 | Lipase powder compositions held by The Nisshin Oillio Group Ltd. and Novozymes A/S In force · Medium confidence | In force | Medium confidence | |
| US 7,141,547 | Albumin Fusion Proteins Comprising GLP-1 Polypeptides held by Novozymes Biopharma DK A/S In force · High confidence | In force | High confidence | |
| US 7,846,711 | Novel Lactobacillus Strains and Uses Thereof held by Novozymes A/S In force · High confidence | In force | High confidence | |
| US 9,451,783 | Phytase Variants held by Novozymes A/S In force · Medium confidence | In force | Medium confidence | |
| US 11,229,223 | Enzyme Granules for Animal Feed held by Novozymes A/S In force · Medium confidence | In force | Medium confidence | |
| US 12,108,776 | Enzyme Granules for Animal Feed held by Novozymes A/S In force · Low confidence | In force | Low confidence | |
| US 9,145,537 | Mashing process held by Novozymes A/S In force · High confidence | In force | High confidence | |
| US 7,892,808 | Protease Variants held by Novozymes A/S In force · High confidence | In force | High confidence |
Also on record, not counted in the 728: 28 patents in force now held by others · 674 patents ended · 307 applications pending · 937 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.